Metabolite pharmacokinetics: the area under the curve of metabolite and the fractional rate of metabolism of a drug after different routes of administration for renally and hepatically cleared drugs and metabolites
- PMID: 7310645
- DOI: 10.1007/BF01060890
Metabolite pharmacokinetics: the area under the curve of metabolite and the fractional rate of metabolism of a drug after different routes of administration for renally and hepatically cleared drugs and metabolites
Abstract
A model comprised of four compartments, a central and liver compartment for a drug, and a central and liver compartment for a metabolite, is presented to describe the interrelationships between the area under the curve of the metabolite and physiological parameters after intravenous and intraportal administration of the drug. The model includes renal and hepatic eliminatory mechanisms for both drug and metabolite as long as the metabolite is formed only by the liver. It is found that when competing renal eliminatory pathways exist for a drug, the area under the curve for the metabolite will change according to the route of drug administration. Also, the fractional rate of metabolism of a drug to form the metabolite will be underestimated by the normal use of the ratio areas under the curve of the metabolite. Other properties of the model are also discussed.
Similar articles
-
The area under the curve of metabolites for drugs and metabolites cleared by the liver and extrahepatic organs. Its dependence on the administration route of precursor drug.Drug Metab Dispos. 1985 Jan-Feb;13(1):97-101. Drug Metab Dispos. 1985. PMID: 2858385
-
A review of metabolite kinetics.J Pharmacokinet Biopharm. 1985 Dec;13(6):633-62. doi: 10.1007/BF01058905. J Pharmacokinet Biopharm. 1985. PMID: 3914545 Review.
-
Theoretical relationships between area under the curve and route of administration of drugs and their precursors for evaluating sites and pathways of metabolism.J Pharm Sci. 1978 May;67(5):703-4. doi: 10.1002/jps.2600670536. J Pharm Sci. 1978. PMID: 641815
-
Kinetics of sequential metabolism. Contribution of parallel, primary metabolic pathways to the formation of a common, secondary metabolite.Drug Metab Dispos. 1995 Feb;23(2):166-77. Drug Metab Dispos. 1995. PMID: 7736907
-
Clinical review: Drug metabolism and nonrenal clearance in acute kidney injury.Crit Care. 2008;12(6):235. doi: 10.1186/cc7093. Epub 2008 Nov 12. Crit Care. 2008. PMID: 19040780 Free PMC article. Review.
Cited by
-
A phase I clinical and pharmacokinetic study of the oral and the oral/intravenous administration of menogaril.Invest New Drugs. 1993 Feb;11(1):17-27. doi: 10.1007/BF00873906. Invest New Drugs. 1993. PMID: 8349432 Clinical Trial.
-
Drug metabolite concentration-time profiles: influence of route of drug administration.Br J Clin Pharmacol. 1984 Apr;17(4):385-94. doi: 10.1111/j.1365-2125.1984.tb02362.x. Br J Clin Pharmacol. 1984. PMID: 6721984 Free PMC article.
-
Absolute bioavailability of clarithromycin after oral administration in humans.Antimicrob Agents Chemother. 1992 May;36(5):1147-50. doi: 10.1128/AAC.36.5.1147. Antimicrob Agents Chemother. 1992. PMID: 1387301 Free PMC article. Clinical Trial.
-
Pharmacokinetics of methysergide and its metabolite methylergometrine in man.Eur J Clin Pharmacol. 1986;30(1):75-7. doi: 10.1007/BF00614199. Eur J Clin Pharmacol. 1986. PMID: 3709634
-
Fractions metabolized in a triangular metabolic system: cinromide and two metabolites in the rhesus monkey.J Pharmacokinet Biopharm. 1985 Aug;13(4):373-86. doi: 10.1007/BF01061475. J Pharmacokinet Biopharm. 1985. PMID: 4087169
References
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Medical